Cardiac function in children post-orthotopic liver transplantation: Echocardiographic parameters and biochemical markers of subclinical cardiovascular damage

Pediatric Transplantation

Volumn 9, Issue 6, 2005, Pages 718-722

  Shalev, Aryeh ^a   Nir, Amiram ^a   Granot, Esther ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

Brain natriuretic peptide; Cardiac function; Children; Echocardiography; Endothelin; Liver transplantation

Indexed keywords

BIOCHEMICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CYCLOSPORIN A; ENDOTHELIN 1; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART EJECTION FRACTION; HEART FUNCTION; HEART INJURY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE OVERLOAD; HUMAN; HUMAN TISSUE; HYPERTENSION; IMAGE ANALYSIS; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; LONG TERM CARE; MALE; MITRAL VALVE; NEPHROTOXICITY; PARAMETER; PHYSICAL EXAMINATION; POSTOPERATIVE PERIOD; RADIOIMMUNOASSAY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADOLESCENT; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY; ENDOTHELIN-1; FEMALE; FOLLOW-UP STUDIES; HEART FUNCTION TESTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; NATRIURETIC PEPTIDE, BRAIN; POSTOPERATIVE COMPLICATIONS; TIME FACTORS;

EID: 27944480958     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2005.00365.x     Document Type: Article

References (27)

1. FAUCI AS, BRAUNWALD E, ISSELBACHER KJ, et al. Disorders of the Gastrointestinal System. Harrison's Principles of Internal Medicine. 14th edn, 1722-1723.
2. GRAHAM RM. Cyclosporine: mechanisms of action and toxicity. Cleve Clin J Med 1994: 61: 308-313.
3. VENTURA HO, MALIK FS, MEHRA MR, STAPELTON DD, SMART FW. Mechanisms of hypertension in cardiac transplantation and the role of cyclosporine. Curr Opin Cardiol 1997: 12: 375-381.
4. GRIEFF M, LOERTSCHER R, SHOHAIB SA, STEWART DJ. Cyclosporine-induced elevation in circulating endothelin-1 in patients with solid-organ transplants. Transplantation 1993: 56: 880-884.
5. TALER SJ, TEXTOR SC, CANZANELLO VJ, SCHWARTZ L. Cyclosporin-induced hypertension: incidence, pathogenesis and management. Drug Saf 1999: 20: 437-449.
6. The U.S. Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994: 331: 1110-1115.
7. TEXTOR SC, WIESNER R, WILSON DJ, et al. Systemic and renal hemodynamic differences between FK-506 and cyclosporine in liver transplant recipients. Transplantation 1993: 55: 1332-1339
8. CANZANELLO VJ, TEXTOR SC, TALER SJ, et al. Late hypertension after liver transplantation: A comparison of cyclosporine and tacrolimus (FK 506). Liver Transpl Surg 1998: 4: 328-334.
9. JAIN A, MAZARIEGOS G, KASHYAP R, et al. Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation. Transplantation 2000: 70: 617-625.
10. NEAL DA, GIMSON AE, GIBBS P, ALEXANDER GJ. Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids and weight. Liver Transpl 2001: 7: 533-539.
11. CHANG RK, ALZONA M, ALEJOS J, JUE K, MCDIARMID SV. Marked left ventricular hypertrophy in children on tacrolimus (FK506) after orthotopic liver transplantation. Am J Cardiol 1998: 81: 1277-1280.
12. CHANG RK, MCDIARMID SV, ALEJOS JC, DRANT SE, KLITZNER TS. Echocardiographic findings of hypertrophic cardiomyopathy in children after orthotopic liver transplantation. Pediatr Transplant 2001: 5: 187-191
13. ROBERTS CA, STERN DL, RADIO SJ. Asymmetric cardiac hypertrophy at autopsy in patients who received FK506 (tacrolimus) or cyclosporine A after liver transplant. Transplantation 2002: 74: 817-821.
14. MEYER-LEHNERT H, BOKEMEYER D, FRIEDRICHS U, BACKER A, KRAMER HJ. Cellular mechanisms of cyclosporine A-associated side effects: role of endothelin. Kidney Int Suppl 1997: 61: S27-31.
15. MONGE JC. Neurohumoral markers of clinical outcome in cardiovascular disease: is endothelin the best one? J Cardiovasc Pharmacol 1998: 32 (Suppl. 2): S36-42.
16. TAKEDA Y, MIYAMORI I, FURUKAWA K, INABA S, MABUCHI H. Mechanisms of FK 506-induced hypertension in the rat. Hypertension 1999: 33: 130-136.
17. MIN DI, CHEN HY, LEE MK, ASHTON K, MARTIN MF. Time-dependent disposition of tacrolimus and its effect on endothelin-1 in liver allograft recipients. Pharmacotherapy 1997: 17: 457-463.
18. LEVIN ER, GARDNER DG, SAMSON WK. Natriuretic peptides. N Engl J Med 1998: 339: 321-328.
19. MAEDA K, TSUTAMOTO T, WADA A, HISANAGA T, KINOSHITA M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998: 135: 825-832.
20. COWIE MR, STRUTHERS AD, WOOD DA, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997: 350: 1349-1353.
21. MEYER RA, Pediatric Echocardiography. Philadelphia: Lea and Febiger, p. 293.
22. O'LEARY PW, DURONGPISITKUL K, CORDES TM, et al. Diastolic ventricular function in children: A Doppler echocardiographic study establishing normal values and predictors of increased ventricular end-diastolic pressure. Mayo Clin Proc 1998: 73: 616-628.
23. LERMAN A, CLICK RL, NARR BJ, et al. Elevation of plasma endothelin associated with systemic hypertension in humans following orthotopic liver transplantation. Transplantation 1991: 51: 646-650.
24. SHIRAKAMI G, MURAKAWA M, SHINGU K, et al. Perioperative plasma concentrations of endothelin and natriuretic peptides in children undergoing living-related liver transplantation. Anesth Analg 1996: 82: 235-240.
25. THERAPONDOS G, FLAPAN AD, DOLLINGER MM, GARDEN OJ, PLEVRIS JN, HAYES PC. Cardiac function after orthotopic liver transplantation and the effects of immunosuppression: a prospective randomized trial comparing cyclosporin (Neoral) and tacrolimus. Liver Transpl 2002: 8: 690-700.
26. YOSHIBAYASHI M, KAMIYA T, SAITO Y, et al. Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: marked and rapid increase after birth. Eur J Endocrinol 1995: 133: 207-209.
27. YOSHIBAYASHI M, NISHIOKA K, NAKAO K, et al. Plasma endothelin levels in healthy children - high values in early infancy. J Cardiovasc Pharmacol 1991: 17 (Suppl. 7): S404-405.